News

A promising new cancer therapy also appears extremely potent against one of the world’s most devastating infectious diseases: tuberculosis (TB). Scientists found the therapy dramatically reduces TB growth, even for bacteria that are drug-resistant.

A genomic tug of war for a gene activator could explain why some cancers respond to decitabine and others don't respond or become resistant over time.

Researchers have discovered previously unknown changes in a specific type of liver cells, potentially opening avenues for a new treatment for liver fibrosis, a potentially life-threatening condition.

Researchers have shed new light on the cellular processes behind Parkinson's and illustrated how disease progression can be halted in a mouse model.

The tension-activated repair patch used in animal trials plugs holes in discs in the spine like car tire patches and could prevent further disease progression.

Researchers have identified the genetic changes that occur during pancreatic cancer metastasis and have found a drug to disrupt the process.

Nearly one in five school-aged children and preteens now take melatonin for sleep, and some parents routinely give the hormone to preschoolers, according to new research.

Researchers have developed an intravenous needle that softens and flexes when in the body, reducing the risk of damage to the blood vessel as patients receive medication.

We’ve known for more than a century that women outlive men. But new research shows that, at least in the United States, the gap has been widening for more than a decade.

Disrupting one gene in CAR T cells used for cancer therapy makes them more potent and able to fight the cancer for longer, reports a new study.